nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—CYP2C9—Leflunomide—systemic scleroderma	0.16	0.368	CbGbCtD
Idarubicin—ABCC1—Methotrexate—systemic scleroderma	0.16	0.367	CbGbCtD
Idarubicin—CYP2D6—Captopril—systemic scleroderma	0.115	0.264	CbGbCtD
Idarubicin—CYP2C9—cardial valve—systemic scleroderma	0.0193	0.742	CbGeAlD
Idarubicin—Doxorubicin—NOS3—systemic scleroderma	0.00812	1	CrCbGaD
Idarubicin—TOP2A—Methyltestosterone—Prednisone—systemic scleroderma	0.00187	1	CbGdCrCtD
Idarubicin—TOP2A—tendon—systemic scleroderma	0.00174	0.0671	CbGeAlD
Idarubicin—TOP2A—lung—systemic scleroderma	0.00153	0.0589	CbGeAlD
Idarubicin—Urinary tract disorder—Mycophenolic acid—systemic scleroderma	0.00135	0.00255	CcSEcCtD
Idarubicin—Myocardial infarction—Lisinopril—systemic scleroderma	0.00134	0.00254	CcSEcCtD
Idarubicin—Alopecia—Azathioprine—systemic scleroderma	0.00134	0.00253	CcSEcCtD
Idarubicin—Anorexia—Mometasone—systemic scleroderma	0.00134	0.00253	CcSEcCtD
Idarubicin—Urethral disorder—Mycophenolic acid—systemic scleroderma	0.00134	0.00253	CcSEcCtD
Idarubicin—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00133	0.00252	CcSEcCtD
Idarubicin—Oesophagitis—Prednisone—systemic scleroderma	0.00133	0.00251	CcSEcCtD
Idarubicin—Hyperuricaemia—Methotrexate—systemic scleroderma	0.00131	0.00248	CcSEcCtD
Idarubicin—Urticaria—Pentoxifylline—systemic scleroderma	0.00129	0.00245	CcSEcCtD
Idarubicin—Immune system disorder—Leflunomide—systemic scleroderma	0.00129	0.00245	CcSEcCtD
Idarubicin—Chest pain—Captopril—systemic scleroderma	0.00129	0.00243	CcSEcCtD
Idarubicin—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00129	0.00243	CcSEcCtD
Idarubicin—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00129	0.00243	CcSEcCtD
Idarubicin—Ulcer—Methotrexate—systemic scleroderma	0.00129	0.00243	CcSEcCtD
Idarubicin—Chills—Leflunomide—systemic scleroderma	0.00128	0.00243	CcSEcCtD
Idarubicin—Arrhythmia—Leflunomide—systemic scleroderma	0.00128	0.00242	CcSEcCtD
Idarubicin—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00242	CcSEcCtD
Idarubicin—Alopecia—Leflunomide—systemic scleroderma	0.00127	0.00239	CcSEcCtD
Idarubicin—Sepsis—Prednisone—systemic scleroderma	0.00126	0.00239	CcSEcCtD
Idarubicin—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00238	CcSEcCtD
Idarubicin—Malnutrition—Leflunomide—systemic scleroderma	0.00125	0.00236	CcSEcCtD
Idarubicin—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00124	0.00234	CcSEcCtD
Idarubicin—Blood uric acid increased—Methotrexate—systemic scleroderma	0.00124	0.00234	CcSEcCtD
Idarubicin—Anaphylactic shock—Captopril—systemic scleroderma	0.00123	0.00233	CcSEcCtD
Idarubicin—Chills—Mycophenolic acid—systemic scleroderma	0.00123	0.00232	CcSEcCtD
Idarubicin—Decreased appetite—Mometasone—systemic scleroderma	0.00122	0.00231	CcSEcCtD
Idarubicin—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00122	0.00231	CcSEcCtD
Idarubicin—Thrombophlebitis—Prednisone—systemic scleroderma	0.00122	0.00231	CcSEcCtD
Idarubicin—Anaemia—Azathioprine—systemic scleroderma	0.00122	0.00231	CcSEcCtD
Idarubicin—Urinary tract disorder—Lisinopril—systemic scleroderma	0.00121	0.0023	CcSEcCtD
Idarubicin—Shock—Captopril—systemic scleroderma	0.00121	0.0023	CcSEcCtD
Idarubicin—Thrombocytopenia—Captopril—systemic scleroderma	0.00121	0.00229	CcSEcCtD
Idarubicin—Alopecia—Mycophenolic acid—systemic scleroderma	0.00121	0.00228	CcSEcCtD
Idarubicin—Urethral disorder—Lisinopril—systemic scleroderma	0.00121	0.00228	CcSEcCtD
Idarubicin—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.0012	0.00227	CcSEcCtD
Idarubicin—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00119	0.00225	CcSEcCtD
Idarubicin—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00224	CcSEcCtD
Idarubicin—Leukopenia—Azathioprine—systemic scleroderma	0.00118	0.00223	CcSEcCtD
Idarubicin—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00223	CcSEcCtD
Idarubicin—Anorexia—Captopril—systemic scleroderma	0.00118	0.00222	CcSEcCtD
Idarubicin—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00221	CcSEcCtD
Idarubicin—Cardiac failure congestive—Prednisone—systemic scleroderma	0.00116	0.0022	CcSEcCtD
Idarubicin—Anaemia—Leflunomide—systemic scleroderma	0.00115	0.00218	CcSEcCtD
Idarubicin—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00115	0.00217	CcSEcCtD
Idarubicin—Flushing—Lisinopril—systemic scleroderma	0.00114	0.00216	CcSEcCtD
Idarubicin—Angiopathy—Lisinopril—systemic scleroderma	0.00112	0.00211	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00112	0.00211	CcSEcCtD
Idarubicin—Leukopenia—Leflunomide—systemic scleroderma	0.00112	0.00211	CcSEcCtD
Idarubicin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00111	0.00211	CcSEcCtD
Idarubicin—Body temperature increased—Mometasone—systemic scleroderma	0.00111	0.0021	CcSEcCtD
Idarubicin—Abdominal pain—Mometasone—systemic scleroderma	0.00111	0.0021	CcSEcCtD
Idarubicin—Chills—Lisinopril—systemic scleroderma	0.0011	0.00209	CcSEcCtD
Idarubicin—Neoplasm—Methotrexate—systemic scleroderma	0.0011	0.00208	CcSEcCtD
Idarubicin—Arrhythmia—Lisinopril—systemic scleroderma	0.0011	0.00208	CcSEcCtD
Idarubicin—Anaemia—Mycophenolic acid—systemic scleroderma	0.0011	0.00208	CcSEcCtD
Idarubicin—Alopecia—Lisinopril—systemic scleroderma	0.00109	0.00206	CcSEcCtD
Idarubicin—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00205	CcSEcCtD
Idarubicin—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00204	CcSEcCtD
Idarubicin—Decreased appetite—Captopril—systemic scleroderma	0.00107	0.00203	CcSEcCtD
Idarubicin—Malnutrition—Lisinopril—systemic scleroderma	0.00107	0.00203	CcSEcCtD
Idarubicin—Infection—Azathioprine—systemic scleroderma	0.00107	0.00202	CcSEcCtD
Idarubicin—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00201	CcSEcCtD
Idarubicin—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00106	0.00201	CcSEcCtD
Idarubicin—Chest pain—Leflunomide—systemic scleroderma	0.00106	0.00201	CcSEcCtD
Idarubicin—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00106	0.002	CcSEcCtD
Idarubicin—Sepsis—Methotrexate—systemic scleroderma	0.00106	0.002	CcSEcCtD
Idarubicin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00105	0.00199	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00105	0.00199	CcSEcCtD
Idarubicin—ABCC1—tendon—systemic scleroderma	0.00105	0.0404	CbGeAlD
Idarubicin—Skin disorder—Azathioprine—systemic scleroderma	0.00105	0.00198	CcSEcCtD
Idarubicin—Vomiting—Pentoxifylline—systemic scleroderma	0.00104	0.00196	CcSEcCtD
Idarubicin—Convulsion—Mycophenolic acid—systemic scleroderma	0.00103	0.00195	CcSEcCtD
Idarubicin—Rash—Pentoxifylline—systemic scleroderma	0.00103	0.00194	CcSEcCtD
Idarubicin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00103	0.00194	CcSEcCtD
Idarubicin—Headache—Pentoxifylline—systemic scleroderma	0.00102	0.00193	CcSEcCtD
Idarubicin—Thrombophlebitis—Methotrexate—systemic scleroderma	0.00102	0.00193	CcSEcCtD
Idarubicin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00102	0.00192	CcSEcCtD
Idarubicin—Chest pain—Mycophenolic acid—systemic scleroderma	0.00101	0.00191	CcSEcCtD
Idarubicin—Infection—Leflunomide—systemic scleroderma	0.00101	0.00191	CcSEcCtD
Idarubicin—Gastrointestinal pain—Captopril—systemic scleroderma	0.00101	0.00191	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00101	0.0019	CcSEcCtD
Idarubicin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000996	0.00188	CcSEcCtD
Idarubicin—Anaemia—Lisinopril—systemic scleroderma	0.00099	0.00187	CcSEcCtD
Idarubicin—Skin disorder—Leflunomide—systemic scleroderma	0.000988	0.00187	CcSEcCtD
Idarubicin—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000978	0.00185	CcSEcCtD
Idarubicin—Abdominal pain—Captopril—systemic scleroderma	0.000976	0.00185	CcSEcCtD
Idarubicin—Body temperature increased—Captopril—systemic scleroderma	0.000976	0.00185	CcSEcCtD
Idarubicin—Anorexia—Leflunomide—systemic scleroderma	0.00097	0.00183	CcSEcCtD
Idarubicin—Nausea—Pentoxifylline—systemic scleroderma	0.000967	0.00183	CcSEcCtD
Idarubicin—Chills—Mycophenolate mofetil—systemic scleroderma	0.000967	0.00183	CcSEcCtD
Idarubicin—Infection—Mycophenolic acid—systemic scleroderma	0.000964	0.00182	CcSEcCtD
Idarubicin—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000963	0.00182	CcSEcCtD
Idarubicin—Diarrhoea—Mometasone—systemic scleroderma	0.000961	0.00182	CcSEcCtD
Idarubicin—Leukopenia—Lisinopril—systemic scleroderma	0.000959	0.00181	CcSEcCtD
Idarubicin—Shock—Mycophenolic acid—systemic scleroderma	0.000955	0.00181	CcSEcCtD
Idarubicin—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000953	0.0018	CcSEcCtD
Idarubicin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00095	0.0018	CcSEcCtD
Idarubicin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000943	0.00178	CcSEcCtD
Idarubicin—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000938	0.00177	CcSEcCtD
Idarubicin—Anorexia—Mycophenolic acid—systemic scleroderma	0.000925	0.00175	CcSEcCtD
Idarubicin—ABCC1—lung—systemic scleroderma	0.000922	0.0355	CbGeAlD
Idarubicin—Chest pain—Lisinopril—systemic scleroderma	0.000912	0.00172	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000906	0.00171	CcSEcCtD
Idarubicin—Vomiting—Mometasone—systemic scleroderma	0.000893	0.00169	CcSEcCtD
Idarubicin—Rash—Mometasone—systemic scleroderma	0.000886	0.00168	CcSEcCtD
Idarubicin—Dermatitis—Mometasone—systemic scleroderma	0.000885	0.00167	CcSEcCtD
Idarubicin—Decreased appetite—Leflunomide—systemic scleroderma	0.000884	0.00167	CcSEcCtD
Idarubicin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000881	0.00167	CcSEcCtD
Idarubicin—Headache—Mometasone—systemic scleroderma	0.00088	0.00166	CcSEcCtD
Idarubicin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000874	0.00165	CcSEcCtD
Idarubicin—Infection—Lisinopril—systemic scleroderma	0.000868	0.00164	CcSEcCtD
Idarubicin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000867	0.00164	CcSEcCtD
Idarubicin—Shock—Lisinopril—systemic scleroderma	0.00086	0.00163	CcSEcCtD
Idarubicin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000856	0.00162	CcSEcCtD
Idarubicin—Neutropenia—Prednisone—systemic scleroderma	0.000854	0.00161	CcSEcCtD
Idarubicin—Abdominal pain—Azathioprine—systemic scleroderma	0.000852	0.00161	CcSEcCtD
Idarubicin—Body temperature increased—Azathioprine—systemic scleroderma	0.000852	0.00161	CcSEcCtD
Idarubicin—Skin disorder—Lisinopril—systemic scleroderma	0.000849	0.00161	CcSEcCtD
Idarubicin—Diarrhoea—Captopril—systemic scleroderma	0.000844	0.0016	CcSEcCtD
Idarubicin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000844	0.0016	CcSEcCtD
Idarubicin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00084	0.00159	CcSEcCtD
Idarubicin—CYP2C9—digestive system—systemic scleroderma	0.000835	0.0321	CbGeAlD
Idarubicin—Nausea—Mometasone—systemic scleroderma	0.000835	0.00158	CcSEcCtD
Idarubicin—Anorexia—Lisinopril—systemic scleroderma	0.000833	0.00158	CcSEcCtD
Idarubicin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000832	0.00157	CcSEcCtD
Idarubicin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000813	0.00154	CcSEcCtD
Idarubicin—Urticaria—Leflunomide—systemic scleroderma	0.000808	0.00153	CcSEcCtD
Idarubicin—Abdominal pain—Leflunomide—systemic scleroderma	0.000804	0.00152	CcSEcCtD
Idarubicin—Body temperature increased—Leflunomide—systemic scleroderma	0.000804	0.00152	CcSEcCtD
Idarubicin—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000802	0.00152	CcSEcCtD
Idarubicin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000799	0.00151	CcSEcCtD
Idarubicin—Myocardial infarction—Prednisone—systemic scleroderma	0.000798	0.00151	CcSEcCtD
Idarubicin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000794	0.0015	CcSEcCtD
Idarubicin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000794	0.0015	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000793	0.0015	CcSEcCtD
Idarubicin—Vomiting—Captopril—systemic scleroderma	0.000785	0.00148	CcSEcCtD
Idarubicin—Rash—Captopril—systemic scleroderma	0.000778	0.00147	CcSEcCtD
Idarubicin—Dermatitis—Captopril—systemic scleroderma	0.000777	0.00147	CcSEcCtD
Idarubicin—Headache—Captopril—systemic scleroderma	0.000773	0.00146	CcSEcCtD
Idarubicin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000767	0.00145	CcSEcCtD
Idarubicin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000767	0.00145	CcSEcCtD
Idarubicin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000766	0.00145	CcSEcCtD
Idarubicin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000761	0.00144	CcSEcCtD
Idarubicin—Decreased appetite—Lisinopril—systemic scleroderma	0.00076	0.00144	CcSEcCtD
Idarubicin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000753	0.00142	CcSEcCtD
Idarubicin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00075	0.00142	CcSEcCtD
Idarubicin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000749	0.00142	CcSEcCtD
Idarubicin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000744	0.00141	CcSEcCtD
Idarubicin—Diarrhoea—Azathioprine—systemic scleroderma	0.000737	0.00139	CcSEcCtD
Idarubicin—Haemoglobin—Prednisone—systemic scleroderma	0.000734	0.00139	CcSEcCtD
Idarubicin—Nausea—Captopril—systemic scleroderma	0.000733	0.00139	CcSEcCtD
Idarubicin—Haemorrhage—Prednisone—systemic scleroderma	0.000731	0.00138	CcSEcCtD
Idarubicin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00073	0.00138	CcSEcCtD
Idarubicin—Pancytopenia—Methotrexate—systemic scleroderma	0.000725	0.00137	CcSEcCtD
Idarubicin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000715	0.00135	CcSEcCtD
Idarubicin—Neutropenia—Methotrexate—systemic scleroderma	0.000713	0.00135	CcSEcCtD
Idarubicin—Diarrhoea—Leflunomide—systemic scleroderma	0.000696	0.00132	CcSEcCtD
Idarubicin—Urticaria—Lisinopril—systemic scleroderma	0.000694	0.00131	CcSEcCtD
Idarubicin—Abdominal pain—Lisinopril—systemic scleroderma	0.000691	0.00131	CcSEcCtD
Idarubicin—Body temperature increased—Lisinopril—systemic scleroderma	0.000691	0.00131	CcSEcCtD
Idarubicin—Vomiting—Azathioprine—systemic scleroderma	0.000685	0.0013	CcSEcCtD
Idarubicin—Rash—Azathioprine—systemic scleroderma	0.000679	0.00128	CcSEcCtD
Idarubicin—Dermatitis—Azathioprine—systemic scleroderma	0.000679	0.00128	CcSEcCtD
Idarubicin—Flushing—Prednisone—systemic scleroderma	0.000678	0.00128	CcSEcCtD
Idarubicin—Headache—Azathioprine—systemic scleroderma	0.000675	0.00128	CcSEcCtD
Idarubicin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000666	0.00126	CcSEcCtD
Idarubicin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000664	0.00126	CcSEcCtD
Idarubicin—Stomatitis—Methotrexate—systemic scleroderma	0.000663	0.00125	CcSEcCtD
Idarubicin—Angiopathy—Prednisone—systemic scleroderma	0.000663	0.00125	CcSEcCtD
Idarubicin—Immune system disorder—Prednisone—systemic scleroderma	0.00066	0.00125	CcSEcCtD
Idarubicin—Arrhythmia—Prednisone—systemic scleroderma	0.000653	0.00123	CcSEcCtD
Idarubicin—Vomiting—Leflunomide—systemic scleroderma	0.000647	0.00122	CcSEcCtD
Idarubicin—Alopecia—Prednisone—systemic scleroderma	0.000646	0.00122	CcSEcCtD
Idarubicin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000644	0.00122	CcSEcCtD
Idarubicin—Rash—Leflunomide—systemic scleroderma	0.000641	0.00121	CcSEcCtD
Idarubicin—Dermatitis—Leflunomide—systemic scleroderma	0.000641	0.00121	CcSEcCtD
Idarubicin—Nausea—Azathioprine—systemic scleroderma	0.00064	0.00121	CcSEcCtD
Idarubicin—Headache—Leflunomide—systemic scleroderma	0.000637	0.00121	CcSEcCtD
Idarubicin—Malnutrition—Prednisone—systemic scleroderma	0.000636	0.0012	CcSEcCtD
Idarubicin—CYP2D6—digestive system—systemic scleroderma	0.000627	0.0241	CbGeAlD
Idarubicin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000626	0.00118	CcSEcCtD
Idarubicin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000617	0.00117	CcSEcCtD
Idarubicin—Haemoglobin—Methotrexate—systemic scleroderma	0.000614	0.00116	CcSEcCtD
Idarubicin—Rash—Mycophenolic acid—systemic scleroderma	0.000612	0.00116	CcSEcCtD
Idarubicin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000611	0.00116	CcSEcCtD
Idarubicin—Haemorrhage—Methotrexate—systemic scleroderma	0.000611	0.00115	CcSEcCtD
Idarubicin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000608	0.00115	CcSEcCtD
Idarubicin—Headache—Mycophenolic acid—systemic scleroderma	0.000608	0.00115	CcSEcCtD
Idarubicin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000605	0.00114	CcSEcCtD
Idarubicin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000605	0.00114	CcSEcCtD
Idarubicin—Nausea—Leflunomide—systemic scleroderma	0.000604	0.00114	CcSEcCtD
Idarubicin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000603	0.00114	CcSEcCtD
Idarubicin—Urethral disorder—Methotrexate—systemic scleroderma	0.000599	0.00113	CcSEcCtD
Idarubicin—Diarrhoea—Lisinopril—systemic scleroderma	0.000598	0.00113	CcSEcCtD
Idarubicin—Anaemia—Prednisone—systemic scleroderma	0.000588	0.00111	CcSEcCtD
Idarubicin—Nausea—Mycophenolic acid—systemic scleroderma	0.000576	0.00109	CcSEcCtD
Idarubicin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000564	0.00107	CcSEcCtD
Idarubicin—Vomiting—Lisinopril—systemic scleroderma	0.000556	0.00105	CcSEcCtD
Idarubicin—Angiopathy—Methotrexate—systemic scleroderma	0.000554	0.00105	CcSEcCtD
Idarubicin—Immune system disorder—Methotrexate—systemic scleroderma	0.000552	0.00104	CcSEcCtD
Idarubicin—Rash—Lisinopril—systemic scleroderma	0.000551	0.00104	CcSEcCtD
Idarubicin—Convulsion—Prednisone—systemic scleroderma	0.000551	0.00104	CcSEcCtD
Idarubicin—Dermatitis—Lisinopril—systemic scleroderma	0.000551	0.00104	CcSEcCtD
Idarubicin—Chills—Methotrexate—systemic scleroderma	0.000548	0.00104	CcSEcCtD
Idarubicin—Headache—Lisinopril—systemic scleroderma	0.000548	0.00104	CcSEcCtD
Idarubicin—Alopecia—Methotrexate—systemic scleroderma	0.00054	0.00102	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000538	0.00102	CcSEcCtD
Idarubicin—Malnutrition—Methotrexate—systemic scleroderma	0.000532	0.00101	CcSEcCtD
Idarubicin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000524	0.000991	CcSEcCtD
Idarubicin—Nausea—Lisinopril—systemic scleroderma	0.000519	0.000982	CcSEcCtD
Idarubicin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000519	0.000982	CcSEcCtD
Idarubicin—Infection—Prednisone—systemic scleroderma	0.000516	0.000975	CcSEcCtD
Idarubicin—Shock—Prednisone—systemic scleroderma	0.000511	0.000966	CcSEcCtD
Idarubicin—Skin disorder—Prednisone—systemic scleroderma	0.000504	0.000954	CcSEcCtD
Idarubicin—Anorexia—Prednisone—systemic scleroderma	0.000495	0.000936	CcSEcCtD
Idarubicin—Anaemia—Methotrexate—systemic scleroderma	0.000491	0.000929	CcSEcCtD
Idarubicin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000487	0.000921	CcSEcCtD
Idarubicin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000483	0.000913	CcSEcCtD
Idarubicin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000482	0.000912	CcSEcCtD
Idarubicin—Headache—Mycophenolate mofetil—systemic scleroderma	0.00048	0.000907	CcSEcCtD
Idarubicin—Leukopenia—Methotrexate—systemic scleroderma	0.000476	0.0009	CcSEcCtD
Idarubicin—Convulsion—Methotrexate—systemic scleroderma	0.000461	0.000871	CcSEcCtD
Idarubicin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000455	0.00086	CcSEcCtD
Idarubicin—Chest pain—Methotrexate—systemic scleroderma	0.000453	0.000856	CcSEcCtD
Idarubicin—Decreased appetite—Prednisone—systemic scleroderma	0.000451	0.000853	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000449	0.00085	CcSEcCtD
Idarubicin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000434	0.00082	CcSEcCtD
Idarubicin—Infection—Methotrexate—systemic scleroderma	0.000431	0.000815	CcSEcCtD
Idarubicin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000425	0.000803	CcSEcCtD
Idarubicin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000424	0.000803	CcSEcCtD
Idarubicin—Skin disorder—Methotrexate—systemic scleroderma	0.000421	0.000797	CcSEcCtD
Idarubicin—Anorexia—Methotrexate—systemic scleroderma	0.000414	0.000782	CcSEcCtD
Idarubicin—Urticaria—Prednisone—systemic scleroderma	0.000412	0.00078	CcSEcCtD
Idarubicin—Abdominal pain—Prednisone—systemic scleroderma	0.00041	0.000776	CcSEcCtD
Idarubicin—Body temperature increased—Prednisone—systemic scleroderma	0.00041	0.000776	CcSEcCtD
Idarubicin—Hypersensitivity—Prednisone—systemic scleroderma	0.000382	0.000723	CcSEcCtD
Idarubicin—Decreased appetite—Methotrexate—systemic scleroderma	0.000377	0.000713	CcSEcCtD
Idarubicin—Diarrhoea—Prednisone—systemic scleroderma	0.000355	0.000672	CcSEcCtD
Idarubicin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000355	0.000671	CcSEcCtD
Idarubicin—Urticaria—Methotrexate—systemic scleroderma	0.000345	0.000652	CcSEcCtD
Idarubicin—Abdominal pain—Methotrexate—systemic scleroderma	0.000343	0.000649	CcSEcCtD
Idarubicin—Body temperature increased—Methotrexate—systemic scleroderma	0.000343	0.000649	CcSEcCtD
Idarubicin—Vomiting—Prednisone—systemic scleroderma	0.00033	0.000624	CcSEcCtD
Idarubicin—Rash—Prednisone—systemic scleroderma	0.000327	0.000619	CcSEcCtD
Idarubicin—Dermatitis—Prednisone—systemic scleroderma	0.000327	0.000618	CcSEcCtD
Idarubicin—Headache—Prednisone—systemic scleroderma	0.000325	0.000615	CcSEcCtD
Idarubicin—Hypersensitivity—Methotrexate—systemic scleroderma	0.00032	0.000604	CcSEcCtD
Idarubicin—Nausea—Prednisone—systemic scleroderma	0.000308	0.000583	CcSEcCtD
Idarubicin—Diarrhoea—Methotrexate—systemic scleroderma	0.000297	0.000561	CcSEcCtD
Idarubicin—Vomiting—Methotrexate—systemic scleroderma	0.000276	0.000522	CcSEcCtD
Idarubicin—Rash—Methotrexate—systemic scleroderma	0.000274	0.000517	CcSEcCtD
Idarubicin—Dermatitis—Methotrexate—systemic scleroderma	0.000273	0.000517	CcSEcCtD
Idarubicin—Headache—Methotrexate—systemic scleroderma	0.000272	0.000514	CcSEcCtD
Idarubicin—Nausea—Methotrexate—systemic scleroderma	0.000258	0.000487	CcSEcCtD
